#you have to pay the salaries of people who breed mice and manufacture microscopes and maintain microscopes for the scientists to use them

[larkiethings]

I was writing this in the tags but I want to include sources. I’m gonna tell you why drugs don’t go generic right away, and I want you to know that I don’t agree with the reasoning here, but this is how the system works.

New drugs are priced so much to recoup some of the losses of research. Drug research is insanely expensive. Whether you’re talking about buffers and reagents in the lab, machines designed to give scientists highly specific information, or required animal research, it’s EXPENSIVE. I tried to pull up an example for a standard microscope but companies that make lab equipment don’t have prices on their website, you have to fill out a form to request a quote.

So, lab equipment is expensive. You also have to go through rounds of animal testing. One lab mouse can cost hundreds of dollars, depending on how it has been genetically designed to give the best research results. And spoiler alert, you need repeat results, meaning multiple mice, and then larger lab animals because humans aren’t mice and we need to be sure drugs are safe before testing them on humans. Raising and caring for lab animals also takes lots of highly trained staff, which adds to the expense. This is partially why a lot of scientists in animal research are pushing for alternative research methods, because it is more humane and more cost effective to reduce our reliance on animal models.

So it’s expensive to do research, and then you get into patent law. Drugs get 20 years of patents, although that’s from when the patent was filed - which is often BEFORE the drug hits the market. You can patent a drug and then still have several more years of development. So in practice, drugs are often on the market for less than their patent time. From the drug company’s perspective, they need to recoup their losses in that amount of time, and the high price of the name brand drug is funding the ongoing research of the next drug.

Generic drugs don’t have to go through animal or clinical trials, so companies making generic drugs ONLY have to consider the manufacturing cost when pricing their drugs. This is why they’re so much cheaper, because all they have to prove is that their drug is the same as the patented one.

Lenacapavir is STILL IN CLINICAL TRIALS, according to the source linked above. It hasn’t been approved for prevention. I believe it will probably be approved, but the point is that it’s a very new drug and still within its patent range. I’m not entirely sure when the patent was filed, but the fact is that it will have a generic eventually. Just not right now. But the reasoning for drugs being so expensive is that they’re factoring in the cost of research, not just the cost of production. I don’t like it! It’s a bad system! But that’s why it is the way it is

Source